Loading company
$31.04+0.4%Nov 11 close
Figures through June 27, 2026, from the 6-K filed August 14, 2026
Past performance
- 1W
- -0.4%
- 1M
- +11.4%
- 3M
- +4.3%
- 6M
- +5.3%
- 1Y
- -3.4%
- 5Y
- -2.0%
Built from Smith & Nephew plc’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
$31.04+0.4%Nov 11 close
Figures through June 27, 2026, from the 6-K filed August 14, 2026
The themes Smith & Nephew is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
MDTMedtronic plc$130BA+
SYKStryker Corp.$121.3BA+
EWEdwards Lifesciences Corporation$60.8BA+
GEHCGE Healthcare Technologies Inc.$37.4BA
GKOSGlaukos Corp$14.6BARose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher CorporationOct 21, 2026CBGraded C, now B
MCKMckesson CorporationNov 4, 2026BAGraded B, now A
CVSCVS Health CorpNov 4, 2026BAGraded B, now AEWEdwards Lifesciences CorporationNov 4, 2026BAGraded B, now A
BIIBBiogen Inc.Oct 28, 2026BAGraded B, now AGrade B
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 11 quarters of Smith & Nephew plc’s grade history. The other 9 go back to March 2018.
